# A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT

> **NCT01639261** · PHASE2 · UNKNOWN · sponsor: **University Hospital Regensburg** · enrollment: 10 (estimated)

## Conditions studied

- Steroid-refractory Bronchiolitis Obliterans

## Interventions

- **DRUG:** Interferon gamma 1b

## Key facts

- **NCT ID:** NCT01639261
- **Lead sponsor:** University Hospital Regensburg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2013-12
- **Final completion:** 2014-09
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2012-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639261, "A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01639261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*